State Street’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Hold |
15,322
| – | – | ﹤0.01% | 4228 |
|
|
2025
Q1 | $7.97K | Hold |
15,322
| – | – | ﹤0.01% | 4259 |
|
|
2024
Q4 | $7.81K | Hold |
15,322
| – | – | ﹤0.01% | 4283 |
|
|
2024
Q3 | $54.2K | Buy |
15,322
+1
| +0% | +$4 | ﹤0.01% | 4087 |
|
|
2024
Q2 | $121K | Buy |
15,321
+2,124
| +16% | +$16.8K | ﹤0.01% | 3952 |
|
|
2024
Q1 | $179K | Sell |
13,197
-1,052
| -7% | -$14.3K | ﹤0.01% | 3895 |
|
|
2023
Q4 | $154K | Hold |
14,249
| – | – | ﹤0.01% | 3949 |
|
|
2023
Q3 | $92.6K | Hold |
14,249
| – | – | ﹤0.01% | 4131 |
|
|
2023
Q2 | $256K | Hold |
14,249
| – | – | ﹤0.01% | 3925 |
|
|
2023
Q1 | $335K | Hold |
14,249
| – | – | ﹤0.01% | 3887 |
|
|
2022
Q4 | $356K | Hold |
14,249
| – | – | ﹤0.01% | 3886 |
|
|
2022
Q3 | $453K | Hold |
14,249
| – | – | ﹤0.01% | 3813 |
|
|
2022
Q2 | $563K | Hold |
14,249
| – | – | ﹤0.01% | 3785 |
|
|
2022
Q1 | $573K | Buy |
14,249
+1,058
| +8% | +$42.5K | ﹤0.01% | 3987 |
|
|
2021
Q4 | $666K | Hold |
13,191
| – | – | ﹤0.01% | 3914 |
|
|
2021
Q3 | $857K | Hold |
13,191
| – | – | ﹤0.01% | 3813 |
|
|
2021
Q2 | $511K | Buy |
13,191
+10,491
| +389% | +$406K | ﹤0.01% | 3845 |
|
|
2021
Q1 | $142K | Buy |
2,700
+166
| +7% | +$8.73K | ﹤0.01% | 3874 |
|
|
2020
Q4 | $172K | Hold |
2,534
| – | – | ﹤0.01% | 3767 |
|
|
2020
Q3 | $97K | Hold |
2,534
| – | – | ﹤0.01% | 3722 |
|
|
2020
Q2 | $98K | Hold |
2,534
| – | – | ﹤0.01% | 3661 |
|
|
2020
Q1 | $76K | Buy |
2,534
+2,200
| +659% | +$66K | ﹤0.01% | 3639 |
|
|
2019
Q4 | $38K | Buy |
+334
| New | +$38K | ﹤0.01% | 3739 |
|
|
2018
Q3 | – | Sell |
-1,023
| Closed | -$23K | – | 3791 |
|
|
2018
Q2 | $23K | Sell |
1,023
-16,291
| -94% | -$366K | ﹤0.01% | 3722 |
|
|
2018
Q1 | $664K | Buy |
17,314
+414
| +2% | +$15.9K | ﹤0.01% | 3398 |
|
|
2017
Q4 | $980K | Sell |
16,900
-950
| -5% | -$55.1K | ﹤0.01% | 3355 |
|
|
2017
Q3 | $1.18M | Buy |
17,850
+4,508
| +34% | +$297K | ﹤0.01% | 3346 |
|
|
2017
Q2 | $1.13M | Buy |
+13,342
| New | +$1.13M | ﹤0.01% | 3315 |
|